EP3072906
Mótefnissamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.12.2009EP published:
8.9.2021EP application number:
16162699.9
EP translation filed:
7.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
8.12.2029Expiry date:
8.12.2026Next due date:
31.12.2026
Title:
ANTIBODY FORMULATION
Timeline
Today
9.12.2009EP application
8.9.2021EP Publication
7.12.2021Translation submitted
15.1.2022Registration published
8.12.2026Expires
Owner
Name:
NOVARTIS AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
MOMM, JoachimAddress:
CH-4002 Basel, CH
Name:
WALLNY, Hans-JoachimAddress:
CH-4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08170884Date:
10.12.2008Country:
EP
Classification
Categories:
C07K 16/24, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 6.12.2021
Expires: 8.12.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 30.11.2022
Expires: 8.12.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 29.11.2023
Expires: 8.12.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 28.11.2024
Expires: 8.12.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.12.2025
Expires: 8.12.2026
Payer: Árnason Faktor ehf.